Clinical Trials Browser

Anemia, Aplastic, Hematologic Diseases, Leukemia, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Large Granular Lymphocytic

NCT00698685 2017-03-31

Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation

Phase 2 Terminated

14 enrolled 7 charts

GenitourinaryLymphoidMyeloidOther hematologic neoplasmPlasma cell

Carcinoma, Renal Cell, Hodgkin Disease, Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00637390 2016-12-02

A Phase I Study of Alemtuzumab in Patients With Relapsed Ovarian/Primary Peritoneal Cancer.

Phase 1 Terminated

3 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00058825 2016-11-07

HIMSUM

Phase 1/2 Terminated

27 enrolled 13 charts

Other hematologic neoplasm

Hematologic Neoplasms

NCT00579111 2016-05-04

Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)

Phase 1/2 Terminated

4 enrolled 8 charts

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hematologic Diseases, Lymphoproliferative Disorders, Multiple Myeloma, Myeloproliferative Disorders, Paraproteinemias, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00578539 2016-04-22

REGALE

Phase NA Terminated

24 enrolled 7 charts

LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Myeloproliferative Disorders

NCT00578903 2016-04-22

Allogeneic Stem Cell Transplant for Patients With Severe Aplastic Anemia

Phase 2 Terminated

22 enrolled 11 charts

Classical hematologyLymphoid

Anemia, Aplastic, Lymphoma, Follicular

NCT00587847 2015-10-15

Campath Maintenance in Chronic Lymphocytic Leukemia

Phase NA Terminated

12 enrolled 5 charts

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00771602 2015-06-23

Alemtuzumab + Rituximab Consolidation in CLL

Phase 2 Terminated

1 enrolled 2 charts

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00943293 2014-03-17

Minor Histocompatibility Vaccination After Allogeneic Stem Cell Transplantation for Advanced Hematologic Malignancies

Phase 1 Terminated

1 enrolled

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Graft vs Host Disease, Lymphoma, Myeloproliferative Disorders, Preleukemia, Neoplasms, Plasma Cell

NCT00818961 2013-12-18

Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer

Phase 2 Terminated

36 enrolled 16 charts

LymphoidMyeloidOther hematologic neoplasm

Congenital Abnormalities, Blast Crisis, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases

NCT00947388 2013-08-22

Bendamustine Plus Alemtuzumab for Refractory Chronic Lymphocytic Leukemia (CLL)

Phase 1 Terminated

9 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT00069992 2012-10-10

MPDMDSBMT

Phase 2 Terminated

7 enrolled

MyeloidOther hematologic neoplasm

Congenital Abnormalities, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Primary Myelofibrosis

NCT00453193 2012-08-07

Alemtuzumab and Pentostatin In T-cell Neoplasms

Phase 2 Terminated

26 enrolled 5 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma

NCT00505921 2011-11-16

Autologous and Allogenic Transplantation With Campath-1H for T-Cell Lymphoma

Phase 2 Terminated

27 enrolled 5 charts

Lymphoid

Lymphoma, Lymphoma, T-Cell

NCT00441025 2009-06-25

The Effectiveness of Alemtuzumab Combination With CHOP to Treat Patients Newly Diagnosed With PTCL

Phase 2 Terminated

4 enrolled

Lymphoid

Lymphoma, T-Cell, Peripheral

Clinical Trials

Alemtuzumab and Clofarabine for Relapsed or Refractory Acute Lymphoblastic Leukemia

THALLO

Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation

Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene

Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders

Cyclophosphamide and Alemtuzumab In Lymphoma

Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies

Cyclosporine Plus Methotrexate or Alemtuzumab

Flu,Alemtuzumab,and TBI Followed By Donor Stem Cell Chronic Phase CML

A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid Tumors

Alemtuzumab in Myelodysplastic Syndrome (MDS), Aplastic Anemia, and T-Cell Large Granular Lymphocytic Leukemia (T-GL)

Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation

A Phase I Study of Alemtuzumab in Patients With Relapsed Ovarian/Primary Peritoneal Cancer.

HIMSUM

Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)

REGALE

Allogeneic Stem Cell Transplant for Patients With Severe Aplastic Anemia

Campath Maintenance in Chronic Lymphocytic Leukemia

Alemtuzumab + Rituximab Consolidation in CLL

Minor Histocompatibility Vaccination After Allogeneic Stem Cell Transplantation for Advanced Hematologic Malignancies

Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer

Bendamustine Plus Alemtuzumab for Refractory Chronic Lymphocytic Leukemia (CLL)

MPDMDSBMT

Alemtuzumab and Pentostatin In T-cell Neoplasms

Autologous and Allogenic Transplantation With Campath-1H for T-Cell Lymphoma

The Effectiveness of Alemtuzumab Combination With CHOP to Treat Patients Newly Diagnosed With PTCL